Cytek Biosciences Inc
CTKB3.785USD
+0.145+3.98%
交易中 （美東）報價延遲15分鐘
482.94M總市值
虧損本益比TTM
關於 Cytek Biosciences Inc 公司
Cytek Biosciences, Inc. 是一家細胞分析解決方案公司。該公司利用其全光譜分析 (FSP) 技術提供高分辨率、高含量和高靈敏度的細胞分析，從而改進細胞分析工具。其 FSP 平臺包括其核心儀器 Cytek Aurora 和 Northern Lights 系統；其細胞分選器 Cytek Aurora CS；Cytek Orion 試劑混合物製備系統；Amnis 和 Guava 品牌下的流式細胞儀和成像產品；以及試劑、軟件和服務，爲客戶提供全面而綜合的解決方案。其 Cytek Aurora 和 Cytek Northern Lights 系統是流式細胞儀，可提供高分辨率、高含量和高靈敏度的細胞分析。其 Cytek Aurora CS 是一種細胞分選器，利用其 FSP 技術的檢測和靈敏度功能，從 40 多種生物標誌物中分離出從低到高複雜度面板的活細胞羣。
公司簡介
公司代碼CTKB
公司名稱Cytek Biosciences Inc
上市日期Jul 23, 2021
CEODr. Wenbin Jiang, Ph.D.
員工數量648
證券類型Ordinary Share
年結日Jul 23
公司地址47215 Lakeview Boulevard
城市FREMONT
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編94538
電話18779229835
網址https://cytekbio.com
公司代碼CTKB
上市日期Jul 23, 2021
CEODr. Wenbin Jiang, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
6.04M
+0.17%
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.26M
+0.70%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
83.67K
+14.04%
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
18.92K
+18.83%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
15.71K
--
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
15.71K
--
Michael Holder
Michael Holder
Independent Director
Independent Director
8.00K
+22.22%
Mr. William (Bill) Mccombe
Mr. William (Bill) Mccombe
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jack T. Ball, Jr.
Mr. Jack T. Ball, Jr.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
6.04M
+0.17%
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.26M
+0.70%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
83.67K
+14.04%
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
18.92K
+18.83%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
15.71K
--
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
15.71K
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Biotechnology, pharmaceutical, distributor and CRO
24.32M
58.68%
Academia and government
17.13M
41.32%
地區USD
名稱
營收
佔比
United States
18.54M
44.71%
EMEA
11.57M
27.90%
APAC
8.89M
21.45%
Other
2.46M
5.95%
業務
地區
業務USD
名稱
營收
佔比
Biotechnology, pharmaceutical, distributor and CRO
24.32M
58.68%
Academia and government
17.13M
41.32%
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.03%
The Vanguard Group, Inc.
6.13%
Brown Capital Management, LLC
5.89%
HHLR Advisors, Ltd.
5.26%
Yan (Ming)
4.77%
Other
64.92%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.03%
The Vanguard Group, Inc.
6.13%
Brown Capital Management, LLC
5.89%
HHLR Advisors, Ltd.
5.26%
Yan (Ming)
4.77%
Other
64.92%
股東類型
持股股東
佔比
Investment Advisor
32.16%
Investment Advisor/Hedge Fund
19.89%
Individual Investor
9.24%
Hedge Fund
3.64%
Pension Fund
2.67%
Research Firm
1.68%
Bank and Trust
0.36%
Venture Capital
0.13%
Family Office
0.05%
Other
30.18%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
323
88.14M
69.58%
-10.95M
2025Q1
332
90.47M
71.35%
-13.48M
2024Q4
323
90.06M
70.25%
-11.48M
2024Q3
303
87.47M
66.52%
-16.26M
2024Q2
288
88.67M
67.45%
-13.39M
2024Q1
284
98.75M
75.24%
-12.70M
2023Q4
276
96.90M
74.11%
-15.57M
2023Q3
266
97.16M
71.81%
-17.75M
2023Q2
259
98.92M
72.71%
-3.90M
2023Q1
228
90.71M
67.01%
-5.56M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
16.50M
13.03%
-335.36K
-1.99%
Mar 31, 2025
The Vanguard Group, Inc.
9.60M
7.58%
-2.09M
-17.92%
Mar 31, 2025
Brown Capital Management, LLC
7.46M
5.89%
-782.64K
-9.49%
Mar 31, 2025
HHLR Advisors, Ltd.
6.66M
5.26%
--
--
Mar 31, 2025
Yan (Ming)
6.04M
4.77%
+10.32K
+0.17%
May 19, 2025
Jiang (Wenbin)
5.26M
4.15%
+36.82K
+0.70%
May 19, 2025
State Street Global Advisors (US)
4.38M
3.46%
-128.20K
-2.84%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.85M
2.25%
+1.02M
+55.91%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.69M
2.12%
+47.59K
+1.80%
Mar 31, 2025
New York State Common Retirement Fund
2.09M
1.65%
--
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco S&P SmallCap Health Care ETF
0.25%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
SPDR S&P 600 Small Cap Value ETF
0.06%
Avantis US Small Cap Equity ETF
0.05%
iShares S&P Small-Cap 600 Value ETF
0.05%
iShares Biotechnology ETF
0.04%
Proshares Ultra Smallcap 600
0.03%
SPDR Portfolio Small Cap ETF (SPSM)
0.03%
Fidelity Enhanced Small Cap ETF
0.03%
iShares ESG Select Screened S&P Small-Cap ETF
0.03%
查看更多
Invesco S&P SmallCap Health Care ETF
佔比0.25%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.06%
SPDR S&P 600 Small Cap Value ETF
佔比0.06%
Avantis US Small Cap Equity ETF
佔比0.05%
iShares S&P Small-Cap 600 Value ETF
佔比0.05%
iShares Biotechnology ETF
佔比0.04%
Proshares Ultra Smallcap 600
佔比0.03%
SPDR Portfolio Small Cap ETF (SPSM)
佔比0.03%
Fidelity Enhanced Small Cap ETF
佔比0.03%
iShares ESG Select Screened S&P Small-Cap ETF
佔比0.03%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
